April 28, 2023
Via: Biopharm InternationalAdaptive Biotechnologies Corporation announced on April 12, 2023 that it has begun a translational collaboration with Takeda. Adaptive Biotechnologies will use its clonoSEQ Assay to assess minimal residue disease (MRD) to start with the development and commercialization of Takeda’s pipeline […]
September 19, 2023
September 14, 2023
September 7, 2023
September 5, 2023
September 1, 2023
September 14, 2023
August 30, 2023
September 20, 2023